Investigating the theragnostic potential of 131I-caerin peptide in thyroid cancer.
CONCLUSION: Iodine-131-Caerin can inhibit the cell viability of thyroid cancer and hold certain promise as a theragnostic tool for human thyroid cancers.
PMID: 32222729 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Nuclear Medicine - Category: Nuclear Medicine Tags: Hell J Nucl Med Source Type: research
More News: Cancer | Cancer & Oncology | Iodine | Nuclear Medicine | PET Scan | Sodium | Study | Thyroid | Thyroid Cancer | Toxicology | Undifferentiated Carcinoma